Back to Search Start Over

Abstract C199: Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules

Authors :
David H. Hawke
Jie Li
Jiyong Liang
Philip L. Lorenzi
Yiling Lu
Huifang Guo
Zhiyong Ding
Gordon B. Mills
Meng Gao
Shanshan Bai
Eric Jonasch
Turgut Dogruluk
Kenneth L. Scott
Source :
Molecular Cancer Therapeutics. 12:C199-C199
Publication Year :
2013
Publisher :
American Association for Cancer Research (AACR), 2013.

Abstract

Aberrant AKT activation is prevalent across multiple human cancer lineages providing an important new target for therapy. Twenty-two independent phosphorylation sites have been identified on specific AKT isoforms likely contributing to differential isoform regulation. However, the mechanisms regulating phosphorylation of individual AKT isoform molecules have not been elucidated due to the lack of robust approaches able to assess phosphorylation of multiple sites on a single AKT molecule. Using a nanofluidic proteomic immunoassay (NIA), consisting of isoelectric focusing followed by sensitive chemiluminescence detection, we demonstrate that under basal and ligand-induced conditions that the pattern of phosphorylation events is markedly different between AKT1 and AKT2. Indeed, there are at least 12 AKT1 peaks and at least 5 AKT2 peaks consistent with complex combinations of phosphorylation of different sites on individual AKT molecules. Following insulin stimulation, AKT1 was phosphorylated at Thr308 in the T-loop and Ser473 in the hydrophobic domain. In contrast, AKT2 was only phosphorylated at the equivalent sites (Thr309 and Ser474) at low levels. Further, Thr308 and Ser473 phosphorylation occurred predominantly on the same AKT1 molecules, whereas Thr309 and Ser474 were phosphorylated primarily on different AKT2 molecules. While basal AKT2 phosphorylation was sensitive to inhibition of PI3K, basal AKT1 phosphorylation was essentially resistant. PI3K inhibition decreased pThr451 on AKT2 but not pThr450 on AKT1. Thus NIA technology provides an ability to characterize coordinate phosphorylation of individual AKT molecules providing important information about AKT isoform-specific phosphorylation, which is required for optimal development and implementation of drugs targeting aberrant AKT activation. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):C199. Citation Format: Huifang Guo, Meng Gao, Yiling Lu, Jiyong Liang, Philip L. Lorenzi, Shanshan Bai, David H. Hawke, Jie Li, Turgut Dogruluk, Kenneth L. Scott, Eric Jonasch, Gordon B. Mills, Zhiyong Ding. Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr C199.

Details

ISSN :
15388514 and 15357163
Volume :
12
Database :
OpenAIRE
Journal :
Molecular Cancer Therapeutics
Accession number :
edsair.doi...........51f75ef054e7ab4e3b2e91165f8762e1
Full Text :
https://doi.org/10.1158/1535-7163.targ-13-c199